Phospholipid analogs useful as PAF synthesis inhibitors
US4761404A · kind A · utility
7Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 1, 1985 |
| Grant date | Aug 2, 1988 |
| Priority date | — |
| Expiry date | Jul 1, 2005 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/58
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
There are disclosed phospholipid analogs which are useful as PAF synthesis inhibitors. These compounds inhibit PAF (platelet-activating factor) biosynthesis and are thereby useful in the treatment of various diseases or disorders mediated by the PAF such as, for example, pain, fever, inflammation, cardiovascular disorder, asthma, lung edema, allergic disorders, skin diseases, psoriasis, and adult respiratory distress syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.